5 Results for "

cTP-AlkF-2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "cTP-AlkF-2" in MCE Product Catalog:

loading...
    loading...
Cat. No.: HY-188197
Target:  

PROTACs DAPK

Research Areas:  

Neurological Disease

VtCD-cTP-ALKF-2 is a DAPK1 PROTAC degrader. VtCD-cTP-ALKF-2 can bind to dephosphorylated DAPK1, recruit VHL E3 ligase, and induce ubiquitin-proteasome-mediated degradation. VtCD-cTP-ALKF-2 can be used for research on Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-188196
Research Areas:  

Neurological Disease

PVtCD-cTP-AlkF-2 is a ROS-responsive DAPK1 BmTAC activator with blood-brain barrier permeability. PVtCD-cTP-AlkF-2 is equipped with a VHL E3 ubiquitin ligase ligand modified with a ROS-responsive phenylboronic acid caging group, and undergoes uncaging activation only in a high-ROS microenvironment. PVtCD-cTP-AlkF-2 can selectively recognize and degrade dephosphorylated activated DAPK1. PVtCD-cTP-AlkF-2 exerts its activator function through caveolae-mediated transcytosis. PVtCD-cTP-AlkF-2 reduces APP and Tau phosphorylation, decreases Aβ oligomer deposition, and improves cognitive function in aged APP/PS1 mice. PVtCD-cTP-AlkF-2 can be used for research on Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-188198
Target:  

Ligands for E3 Ligase

Research Areas:  

Others

VHL Ligand 44 is an E3 ubiquitin ligase ligand that recruits VHL. VHL Ligand 44 can be used to synthesize PROTACs, such as PVtCD-cTP-AlkF-2 (HY-188196) .
loading...
    loading...
Cat. No.: HY-P12376
CAS No.: 1432595-61-3
Target:  

DAPK Drug Intermediate

Research Areas:  

Neurological Disease

DAPK1-binding peptide is a peptide derived from GluN2B that selectively recognizes the activated, dephosphorylated DAPK1 kinase. DAPK1-binding peptide can serve as the binder moiety of PVtCD-cTP-AlkF-2 (HY-188196) .
loading...
    loading...